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Newts regenerate lost limbs through a complex process involving dedifferentiation, migration, proliferation, and redifferentiation of cells
proximal to the amputation plane. To identify the genes controlling these cellular events, we performed a differential display analysis between
regenerating and nonregenerating limbs from the newt Notophthalmus viridescens. This analysis, coupled with a direct cloning approach,
identified a previously unknown Notophthalmus collagenase gene (nCol) and three known matrix metalloproteinase (MMP) genes, MMP3/
10a, MMP3/10b, and MMP9, all of which are upregulated within hours of limb amputation. MMP3/10b exhibits the highest and most
ubiquitous expression and appears to account for the majority of the proteolytic activity in the limb as measured by gel zymography. By
testing purified recombinant MMP proteins against potential substrates, we show that nCol is a true collagenase, MMP9 is a gelatinase,
MMP3/10a is a stromelysin, and MMP3/10b has an unusually broad substrate profile, acting both as a stromelysin and noncanonical
collagenase. Exposure of regenerating limbs to the synthetic MMP inhibitor GM6001 produces either dwarfed, malformed limb regenerates
or limb stumps with distal scars. These data suggest that MMPs are required for normal newt limb regeneration and that MMPs function, in
part, to prevent scar formation during the regenerative process.
D 2004 Elsevier Inc. All rights reserved.
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Newts and other salamanders have the remarkable ability
to regenerate their limbs, tails, jaws, spinal cords, lenses,
retinas, and heart ventricles (Brockes and Kumar, 2002;
Butler and Ward, 1967). This regenerative ability is depend-
ent upon an unusual degree of cellular plasticity near the site
of injury. Following limb amputation, epithelial cells
proximal to the amputation plane convert to a migratory
form and cover the wound completely within 24 h, while0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.12.003
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E-mail address: odelberg@howard.genetics.utah.edu (S.J. Odelberg).internal limb cells begin to dedifferentiate to form a mass of
proliferating progenitor cells known as the regeneration
blastema (Bodemer and Everett, 1959; Chalkley, 1954; Hay
and Fischman, 1961). The newly-formed wound epithelium
(WE) is required for the growth of the regenerating
salamander limb (Mescher, 1976; Thornton, 1957) and its
later derivative, the apical epithelial cap (AEC), can even
promote supernumerary limb formation when transplanted to
a more proximal region of an existing regeneration blastema
(Thornton and Thornton, 1965). In the newt Notophthalmus
viridescens, dedifferentiation begins in the first week
following limb loss and the blastemal stage lasts through
the third or fourth week of regeneration. Complete replace-
ment of the limb occurs within 5–7 weeks (Wallace, 1981).
Although previous studies have identified many of the
early cellular events leading to the formation of the WE/279 (2005) 86–98
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the molecular mechanisms that control these processes.
Candidate genes upregulated during the early phases of limb
regeneration include matrix metalloproteinases (MMPs).
MMPs were discovered in 1962 as proteases capable of
digesting the collagen present in the tail skin, gills, and
intestines of bullfrog tadpoles (Gross and Lapiere, 1962). It
was soon demonstrated that a similar collagenolytic activity
was also present in the regenerating limbs of newts but
absent in nonregenerating limbs (Grillo et al., 1968). Over
the past four decades, more than 25 vertebrate MMPs have
been identified and classified into groups according to their
protein structure and substrate specificity. These groups
include collagenases (MMP1, MMP8, MMP13, and
MMP18), gelatinases (MMP2 and MMP9), stromelysins
(MMP3, MMP10, and MMP11), and the membrane-type
MMPs (MMP14, MMP15, MMP16, MMP17, MMP24, and
MMP25) (Sternlicht and Werb, 2001). Most MMPs are
secreted in a latent form and must be activated by cleavage
of an N-terminal propeptide domain. Activation can occur
through the actions of other proteases, chaotropic agents, or
organomercuric compounds such as 4-aminophenylmercuric
acetate (APMA). Although MMP activity is known to
increase during salamander limb regeneration (Grillo et al.,
1968; Park and Kim, 1999; Yang and Bryant, 1994) and
some of the MMP genes responsible for this activity have
been cloned (Kato et al., 2003; Miyazaki et al., 1996; Yang
et al., 1999), previous studies have not established whether
these proteases are required for the regenerative process nor
have they investigated the biochemical function of sala-
mander MMPs through substrate analysis.
We have performed a differential display analysis between
regenerating and nonregenerating limbs from N. viridescens
to identify genes that might play important roles in the initial
stages of regeneration. This screen, coupled with a direct
cloning approach, has identified a new Notophthalmus
collagenase gene (nCol) and three MMP genes previously
cloned in other species,MMP3/10a,MMP3/10b, andMMP9,
all of which are upregulated within hours of limb amputation.
We have determined the temporal and spatial expression
patterns for each of these MMP genes, have characterized the
substrate specificities of their recombinant proteins, and
assessed their in vivo function by performing MMP inhibitor
studies during the regenerative process. We conclude that
MMPs are required for normal limb regeneration and that
they apparently function, in part, to prevent scar formation
during the regenerative process.Materials and methods
Newt limb amputations
All procedures involving newts were approved by the
University of Utah Institutional Animal Care and Use
Committee. Limb amputations were performed as previ-ously described (McGann et al., 2001), except that the
bone was not trimmed following amputation. The limbs
were reamputated 1.5–2.5 mm proximal to the distal tip of
the regenerating limb.
Differential display analysis
Differential display was performed according to the
manufacturer’s instructions (GenHunter) using 80 random
primers and three oligo-dT primers containing either a dA,
dG, or dC on their 3V-ends. Total RNA from regenerating
(days 1, 3, and 5) and intact (day 0) newt limbs was isolated
for analysis. Differentially-displayed cDNA fragments were
excised from the polyacrylamide gel, eluted, and ream-
plified. The reamplified cDNAs were TA cloned into
pBluescript II, and multiple clones were selected, restriction
mapped, and sequenced.
Northern blot analysis
Northern blot analysis was performed on RNA extracted
from regenerating newt limbs at 0, 18, 24, and 72 h and 5,
10, 15, 20, 25, 30, 35, and 40 days postamputation. Total
RNA (2–10 Ag) was separated on 1% denaturing agarose
gels in 1 MOPS buffer (20 mM MOPS, 5 mM sodium
acetate, 1 mM EDTA, pH 7) containing 0.5 M form-
aldehyde, transferred to Hybond N+ nylon membrane
(Amersham Pharmacia), and stained with methylene blue
to assess transfer efficiency and RNA loading equivalency
between lanes. The blots were hybridized with [32P]-a-
dCTP-labeled probes and phosphorimaging was performed
using a Storm 860 (Molecular Dynamics). Signals were
normalized using densitometric analysis of the methylene
blue-stained 28S and 18S rRNAs.
RLM-RACE and sequencing of full-length cDNAs
cDNAs containing the full-length open reading frames
for MMP3/10a, MMP3/10b, and MMP9 were obtained by
RNA ligase-mediated-rapid amplification of cDNA ends
(RLM-RACE) according to the manufacturer’s instructions
(Ambion) with the following minor modifications. Follow-
ing linker attachment to the decapped 5V-ends of the
mRNAs, oligo-dT 3V-primers and Superscript II were used
for first strand cDNA synthesis. Nested PCR was then
performed using PfuUltra DNA polymerase (Stratagene) or
Advantage Taq (Clontech) in the presence of 5V-linker
primers and 3V-specific gene primers, which were con-
structed based on the sequences obtained from differential
display products. The amplification products were gel
purified, TA cloned into pBluescript II, and sequenced.
nCol was cloned in two steps. First, the 5V-end of the cDNA,
which contained all but the last 24 bp of the open reading
frame, was cloned as described above. The remaining 24 bp,
which included the stop codon, was added by PCR
amplification of the 5V-end of the cDNA using a 3V-primer
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NotI restriction site for directional cloning. The 5V-primer
contained the restriction site HindIII for directional cloning.
The amplification product was gel purified, directionally
cloned into pBluescript II, and sequenced. Comparisons of
predicted amino acid sequences were done using either the
BLAST 2 sequences (Tatusova and Madden, 1999) or
Clustal W programs (Thompson et al., 1994).
Primer sequences used to clone the above genes are shown
below. The BamHI, HindIII, and NotI sites, which were used
for some of the cloning procedures, are underlined.
Ambion 5V-RACE primers:5V-RACE outer primer, 5V-GCTGATGGCGATGAATGAACACTG-3V;
5V-RACE inner primer 5V-CGCGGATCCGAACACTGCGTTTGCTGG-
CTTTGATG-3V;Specific 3V-MMP primers:MMP3/10a 3V-outer primer, 5V-AAACATACACTTAATAAGTATTTTGTT-
CTG 3V;
MMP3/10a 3V-inner primer, 5V-TAAACCAAGTTTTCAGCATTGAATTC-
TAG-3V;
MMP3/10b 3V-outer primer, 5V-CAAGCTGAATTTAGTGCTCTTTCAAC-
3V
MMP3/10b 3V-inner primer, 5V-AGTAAACTTTTATCAACAACT-
GAACCA-3V
MMP9 3V-outer primer, 5V- CTGAAAACACACACATCCTAACCTTG-3V;
MMP9 3V-inner primer, 5V-TCAAATCTTGTGGCACTTGCGCCAGG-3V;
nCol 3V-outer primer, 5V-GAAAGACCATGTGTGCCGCTAGTAAGCAT-
AG-3V;
nCol 3V-inner primer, 5V-GCTGTTGTTCCTCAAGACCCGCAT-
CACTCTC-3V;
nCol 5V-full-length primer, 5V-CACACACACAAAGCTTAAAAGGGAT-
CAGAGAAACTTGTCCAC-3V;
nCol 3V-full-length primer, 5V-CACACACACAGCGGCCGCGGGCTT-
TATGCTTCTTGACATCCCAACCAGCTGTTGTTCCTCAAGACCC-
GCATCAC-3V;RNA in situ hybridization
One-, five-, and fifteen-day limb regenerates were
amputated at the shoulder and the limbs were fixed
overnight in Carnoy’s fixative (60% ethanol, 30% chloro-
form, 10% glacial acetic acid). Following 24 h of decal-
cification in Morse’s solution (387 mM sodium citrate,
22.5% formic acid), the limbs were washed with PBS and
dehydrated through a series of ethanol/PBS washes with
increasing ethanol concentration. The samples were equi-
librated in Hemo-De, embedded in paraffin, and sectioned
at 10 Am. The paraffin was removed with Hemo-De and
the sections were rehydrated and postfixed with 4%
paraformaldehyde in PBS for 15 min. Endogenous alkaline
phosphatases were inhibited by treatment with 0.2 M HCl
in PBS for 8 min. The tissues were digested with 5 Ag/ml
proteinase K for 15 min at 378C, acetylated in 0.25%
acetic anhydride (v/v) in 0.1 M triethanolamine for 15 min,
and prehybridized for 30 min. Heat denatured digoxigenin-labeled riboprobe (250–500 ng/ml) in 50% formamide, 4
SSC, 1 Denhardt’s solution, 500 Ag/ml heat denatured
herring sperm DNA, 200 Ag/ml yeast RNA, and 10% PEG
6000 was added, and the samples were placed in a
humidified chamber at 558C overnight. The tissues were
washed in buffer, treated with 40 Ag/ml RNase A for 30
min at 378C, and washed again. After blocking the tissues
in 0.5% blocking reagent (Roche) for 30 min, the samples
were treated for 1 h at room temperature with a 1/100
dilution of alkaline phosphatase-conjugated sheep anti-
digoxigenin antibody (Roche) in 0.5% blocking reagent.
The slides were washed and the sections were incubated
20 h in the dark at room temperature with NBT/BCIP
substrate. The sections were mounted and observed using a
light microscope.
Purification of proteins by affinity chromatography
cDNAs containing complete open reading frames (ORFs)
were FLAG-tagged (amino acid sequence DYKDDDDK)
on the 3V-end of their ORFs by PCR using PfuUltra DNA
polymerase. The PCR products were directionally cloned
into the mammalian expression vector pBK-CMV using
either BamHI and NotI or HindIII and NotI, depending
upon the restriction sites present in the amplification
primers. The MMP inserts were completely sequenced to
ensure that no nucleotide substitutions had occurred during
the amplification procedure and were then subcloned
directionally into pCMV-SPORT6 (Invitrogen) using the
SalI and NotI sites in both vectors. The pCMV-SPORT6
clones were used for preparation of the recombinant MMP
proteins, because they consistently produced higher
protein yields than the pBK-CMV constructs. Each of
the expression clones was separately transfected into
human embryonic kidney 293H cells using Lipofect-
amine2000 (Invitrogen), and 100–200 ml of serum-free
conditioned DMEM medium was collected from the
transfected cells at 24–96 h post-transfection. FLAG-
tagged proteins from the conditioned medium were
purified by affinity chromatography according to the
manufacturer’s instructions using 300 Al of packed resin
conjugated to anti-FLAG M2 antibody (Sigma). Concen-
trations of the affinity purified proteins were determined
by comparison to a FLAG-tagged bovine alkaline phos-
phatase standard (Sigma) following Western blotting and
chemiluminescence detection using the SuperSignal West
Femto reagent (Pierce).
Primer sequences used for making the FLAG-tagged
MMPs are shown below. Underlined sequences are either
NotI or HindIII sites, italicized sequences are the comple-
ment of the stop codon, bold sequences are the complement
of the FLAG-tag, uppercase, normal character sequences are
gene specific, and lowercase sequences are nonspecific
5Vprotective sequences designed to enable cleavage at the
restriction sites. nCol 5V-full-length primer (see above for
sequence); nCol 3V-FLAG primer, 5V-cagtcaGCGGCCGCT-
V. Vinarsky et al. / Developmental Biology 279 (2005) 86–98 89TACTTATCGTCGTCATCCTTGTAATCTGCTTCTT-
GACATCCCAACCAGC-3V; MMP3/10b 5V-primer is the 5V-
RACE inner primer (see above for sequence); MMP3/10b
3V-FLAG primer, 5V-cagtcaGCGGCCGCTTATCACT-
TATCGTCGTCATCCTTGTAATCACAACTGAAC-
CAGCTGTTTTTCGTCAG-3V; MMP3/10a 5V-primer is the
5V-RACE inner primer (see above for sequence); MMP3/10a
3V-FLAG primer, 5V-cagtcaGCGGCCGCTTACTTATCGT-
CGTCATCCTTGTAATCACACCGTAACCAGC Q
TGGTGTTCTTCAG-3V; MMP9 5V-primer, 5V-cacacacacaAQ
AGCTTGAACACTGCGTTTGCTGGCTTTGATG-3V;
MMP9 3V-FLAG primer, 5V-cagtcaGCGGCCGCCTACT-
TATCGTCGTCATCCTTGTAATCATTCTCGGGG-
CAATTCAAGATGTCG-3V.
Preparation of regeneration and intact limb extracts
Regenerating newt limbs were collected at various
time points following amputation, flash frozen in liquid
nitrogen, and stored at 808C for later extraction. Intact
limbs were also collected and stored similarly. Regener-
ation and intact limb extracts were prepared as previously
described (McGann et al., 2001) and stored at 808C
until needed.
Zymography
0.1% gelatin and 0.1% casein zymography gels were
purchased from Bio-Rad. Purified FLAG-tagged nCol,
MMP3/10b, MMP3/10a, and MMP9 (30 fmol to 1.5 pmol)
or regeneration and intact limb extracts (15–25 Ag) were
separated by electrophoresis for 90 min at 100 V through
gelatin and casein zymography gels. The MMPs were
renatured in three washes of 2.5% Triton X-100 (10 min
each), followed by an 18–24 h incubation in development
buffer (50 mM Tris–HCl, pH 7.6, 10 mM CaCl2, 50 mM
NaCl, 0.05% Brij-35). Gels were stained with Coomassie
blue R250 for ~1 h and then destained in multiple changes
of a 40% methanol/10% acetic acid solution until clear
bands were visible (2–3 h).
DQ- and BODIPY-substrate assays
DQ-gelatin, DQ-collagen I, DQ-collagen IV (100 Ag/ml),
and BODIPY FL-casein (10 Ag/ml) substrates (Molecular
Probes) were mixed with 1.5 pmol of purified nCol, MMP3/
10b, MMP3/10a, or MMP9 in the presence of 1 mM APMA
and enzyme activation buffer (50 mM Tris–HCl, pH 7.6,
150 mM NaCl, 5 mM CaCl2, 1 AM ZnSO4, and 0.05% Brij-
35). Controls consisted of mixtures of purified MMP protein
and substrate without APMA activation and mixtures of
AMPA and substrate alone. For the inhibitor assays, 2 AM
GM6001 was mixed with the individual MMPs in 1 mM
APMA. Fluorescence signals were measured on a Perkin-
Elmer Fusion a microplate reader at various time points up
to 3 days.Rat tail type I collagen assay
Native rat tail type I collagen (0.5 mg/ml) was mixed
with either APMA-preactivated MMP proteins (5–14 nM)
or with the purified proMMP proteins (5–14 nM) plus 1
mM APMA in enzyme activation buffer (see above) and
incubated for 6–24 h at 258C or 308C. Following the
incubation period, one quarter volume of 4 reducing
SDS loading buffer was added to the reactions and the
samples were heated to 958C for 3 min to denature the
proteins. The samples were separated by SDS–PAGE at
180 V until the bromophenol blue ran off the bottom of
the gel and then stained with Gelcode Blue (Pierce).
Controls included mixtures of either unactivated proMMP
and rat tail type I collagen or APMA plus rat tail type I
collagen.
In vivo GM6001 studies
Following limb amputation and a 1 h recovery period
on ice, newts were housed in one of the following
solutions: (1) 50 AM GM6001/1% DMSO in dechlorinated
tap water; (2) 1% DMSO in dechlorinated tap water; or (3)
dechlorinated tap water. Fresh solutions were either
prepared every 4 days, or alternatively, the solutions were
sterile filtered with a 0.2 Am filter every 4 days and
entirely replaced every 8 days. The inhibitory activity of
the used GM6001 solution was confirmed by its ability to
inhibit MMPs during gel zymography. Following 60 days
of regeneration, the limbs were amputated at the shoulder,
fixed in Carnoy’s fixative overnight, decalcified for 1 h in
a 2 M HCl/PBS/0.5% Triton X-100 solution, and
neutralized in 100 mM sodium borate (pH 8.4) for 5
min. The limbs were washed twice in PBS, dehydrated,
embedded in paraffin, and sectioned at 10 Am. The
sections were stained with hematoxylin and eosin, and
photographs and bone measurements were taken using a
Zeiss Axiocam and Axiovision software. The length of the
regenerated humerus was measured from the distal end of
the ossified bone to the end of the cartilaginous humerus.
Length and width measurements represent maximum
values.Results
Cloning of N. viridescens MMP genes
Differential display analyses between 1-, 3-, and 5-day
limb regenerates and intact limbs identified three MMP
genes that were upregulated during the early stages of
limb regeneration. Full-length cDNAs were generated for
each of these genes using RLM-RACE. Sequence analysis
revealed that one of the genes, nCol, was a previously
unknown newt collagenase with a predicted amino acid
sequence sharing 64%/78% identity/similarity (I/S) with
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I/S with the human collagenases MMP1, MMP8, and
MMP13, respectively (Fig. 1A). From sequence analysis
alone, it is unclear which, if any, of the known
collagenases is orthologous to this newt MMP. Further-Fig. 1. Deduced amino acid sequences of N. viridescens (Nv) MMPs and compari
laevis (Xl) MMP18 and the human (Hs) collagenases MMP1, MMP8, and MMP13
closely related MMPs from either X. laevis or C. pyrrhogaster (Cp). The major do
bind zinc are in bold. The shaded boxes highlight the cysteine switch region involve
Met turn sequence that lies downstream of the zinc-binding motif. GenBank a
AY857751 (MMP3/10a), AY857754 (MMP3/10b), and AY857752 (MMP9).more, biochemical functional analyses (see below) dem-
onstrate that nCol has a slightly different substrate profile
than its closest known homolog, Xenopus MMP18,
suggesting that these two proteases might not be ortho-
logs. Two of the upregulated MMP genes are orthologs ofson to MMPs from other species. (A) The nCol sequence is compared to X.
. (B) The four N. viridescens MMPs are compared to each other and the most
mains are delineated by the double arrowed lines. The histidine residues that
d in maintaining MMP latency, while the white boxes identify the conserved
ccession numbers for the sequences reported here are AY857753 (nCol),
Fig. 2. Temporal RNA expression and proteolytic activity of MMPs during
newt limb regeneration. (A) Northern blot analyses of nCol, MMP9,
MMP3/10a, and MMP3/10b during the first 40 days of limb regeneration.
Each lane contained 2 Ag of total RNA. Membranes were stained with
methylene blue to assess loading equivalency and transfer efficiency and to
allow for normalization of RNA between lanes. An example of a membrane
stained with methylene blue is shown in the bottom panel. (B) Gelatin and
casein zymography were used to assess MMP activity over the first 40 days
of limb regeneration. Each lane contained 15 Ag of limb extract. Numbers
above the lanes refer to hours or days postamputation.
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sequences exhibiting 95%/98% and 94%/95% I/S, respec-
tively, to the corresponding genes from C. pyrrhogaster
(Fig. 1B).
A full-length N. viridescens MMP3/10b cDNA was
cloned by RLM-RACE using primers based on C. pyr-
rhogaster sequences and RNA collected from early limb
regenerates. We confirmed the 3V-end of the RLM-RACE
sequence, which contained the original C. pyrrhogaster
primer sequence, by subsequent 3V-RACE and sequencing.
The predicted amino acid sequence for N. viridescens
MMP3/10b revealed 87%/93% I/S to the corresponding
C. pyrrhogaster sequence (Fig. 1B).
Temporal RNA expression patterns of MMP genes during
limb regeneration
Temporal RNA expression patterns were obtained for
each of the MMP genes during the first 40 days of newt
limb regeneration. Northern blot analyses demonstrated that
nCol and MMP9 followed bimodal expression patterns
(Fig. 2A). Both genes reached maximum expression levels
24 h postamputation (nCol, 11-fold upregulation; MMP9,
10-fold), reduced their expression levels by day 3, and then
reached a second peak at 10–15 days postamputation (9-
and 7-fold, respectively). MMP3/10a and MMP3/10b were
similarly upregulated within hours of limb amputation,
reaching maximum expression levels at 18–24 h (19- and
21-fold, respectively). Following this initial burst, RNA
expression for MMP3/10b returned to preamputation levels
by regeneration day 30, while MMP3/10a expression
rapidly declined and returned to preamputation levels by
days 10–15. The degree of upregulation was determined by
phosphorimaging analysis and normalization to the 28S and
18S rRNA bands following methylene blue staining (see
Materials and methods).
Temporal MMP proteolytic activity during newt limb
regeneration
Proteolytic analyses of regenerating limb extracts using
casein and gelatin zymography revealed that the activities
of certain proteases increase markedly during the early
stages of limb regeneration (Fig. 2B). These proteases are
inhibited by the MMP inhibitor GM6001 (see below) and
5 mM EDTA, but not by 1 mM phenylmethylsulfonyl
fluoride (PMSF) (data not shown), confirming that they are
bona fide MMPs. Both casein and gelatin zymography
revealed a prominent ~20 kDa MMP whose activity
increased within 4–6 h of limb amputation and reached its
peak by 24 h. The activity of the 20 kDa MMP remained
high through regeneration day 20 and returned to preampu-
tation levels by day 40. Several other caseinolytic MMPs,
ranging in size from 25 to 60 kDa, exhibited increased
activity during the early stages of limb regeneration. In
addition to the prominent 20 kDa MMP, gelatin zymog-raphy revealed the presence of three other MMPs with
molecular weights of 60, 70, and 85 kDa. The 85 kDa
MMP exhibited a bimodal activity pattern with peaks at 18–
24 h and 10–20 days postamputation. The activities of the
60 and 70 kDa MMPs remained low through regeneration
day 10, then increased slightly by day 15, and remained
marginally elevated through day 40.
It is possible to tentatively assign most of the MMPs
identified by zymography to MMPs known to be upregu-
lated during newt limb regeneration based on size, substrate
specificity, and a comparison of temporal functional activity
to temporal RNA expression patterns. The 85 kDa MMP
present on gelatin zymography but absent on casein
zymography is likely MMP9, while the prominent 20 kDa
MMP is most likely MMP3/10b. When purified MMP3/10b
Fig. 4. Purification of newt MMP recombinant proteins. (A) Western blot of
affinity-chromatography purified FLAG-tagged nCol, MMP3/10b, MMP3/
10a, and MMP9. Anti-FLAG M2 antibody was used as primary antibody
and the signals were detected by chemiluminescence. (B) The purified
proteins separated by SDS–PAGE and stained with Gelcode Blue (Pierce). A
lane containing conditioned medium from HEK 293 cells is shown to
illustrate the degree of purification.
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temperature or 378C for 1–7 days, several active forms of
the protease are generated ranging in size from 20 to 45
kDa (data not shown). However, purified MMP3/10a does
not produce an active 20 kDa MMP when processed
similarly. This suggests that the 20 kDa MMP present in the
regeneration extract is produced either by MMP3/10b self-
processing or by cleavage of MMP3/10b with another
protease. The 25–60 kDa MMPs present on both gelatin and
casein zymography gels are most likely latent or alter-
natively processed forms of MMP3/10b and MMP3/10a.
This interpretation is consistent with previous reports
demonstrating that mammalian stromelysins, which can
digest both gelatin and casein, exist in several active forms
ranging in size from 21 to 45 kDa (Chin et al., 1985; Marcy
et al., 1991; Sanchez-Lopez et al., 1988).
Spatial expression patterns of MMP genes
RNA in situ hybridization of fixed tissue sections taken
from early limb regenerates revealed the spatial expression
patterns of each MMP gene (Fig. 3). The expression of each
of these genes can be assigned to cells found in anatomically-Fig. 3. RNA in situ hybridization of newt limb regenerates. (A and C) nCol antis
periosteal cells (left arrow), and bone marrow cells (lower arrow) in a 5-day limb re
(C). (E and G) MMP9 antisense riboprobe hybridizes to the basal cell layer of the
(lower middle arrow), and cells in the region of the dedifferentiating muscle (lowe
blastemal cells in the 15-day regenerate (G). (I) MMP3/10b antisense riboprobe hy
in the region where muscle dedifferentiation is occurring (lower arrow). (K) M
(arrow). (B, F, J, and L) Sense riboprobe controls for nCol, MMP9, MMP3/10b,
Sense riboprobe controls for nCol and MMP9, respectively, for 15-day regenerate
regenerating limb.or histologically-defined regions of the regenerating limb.
From days 1 to 5 postamputation, nCol is expressed in bone
marrow cells, periosteal cells, and the basal cell layer of theense riboprobe hybridizes to the basal cell layer of the AEC (upper arrow),
generate (A) and expands to include blastemal cells in the 15-day regenerate
AEC (upper arrow), bone marrow cells (lower left arrow), periosteal cells,
r right arrow) in a 5-day limb regenerate (E) and greatly expands to include
bridizes to the basal cell layer of the AEC (upper arrow) and to internal cells
MP3/10a antisense riboprobe hybridizes to cells in the wound epithelium
and MMP3/10a, respectively, for 1- or 5-day limb regenerates. (D and H)
s. For each gene, matched antisense and sense sections were from the same
Fig. 5. Biochemical activity of the purified newt MMP proteins. (A)
Gelatin and casein zymography. MMP3/10a and MMP3/10b digest both
gelatin and casein, MMP9 digests gelatin but not casein, and nCol digests
neither substrate. Each lane contains 100 fmol of purified protein. (B)
nCol digests rat tail type I collagen (Rat Col I), yielding the characteristic
TCA (3/4) and TCB (1/4) collagen I fragments following SDS–PAGE.
MMP3/10b digests Rat Col I yielding numerous small degradation
products (sdp) that are b25 kDa in length. MMP3/10a exhibits little, if
any, activity toward Rat Col I, while MMP9 has no activity toward Rat
Col I. Two a1 and a single a2 peptide chain comprise the native triple
helical form of Rat Col I. (C) The time-dependent dequenching of DQ-
Collagen I, DQ-Collagen IV, DQ-gelatin, or BODIPY-casein by digestion
of these substrates with activated newt MMPs. Gray x’s, nCol activity;
gray squares, MMP3/10b activity; black diamonds, MMP3/10a activity;
and black triangles, MMP9 activity.
Table 1








nCol +++    
MMP3/10b +++ +++ +++ +++ +++
MMP3/10a  +++ +++ +++ +++
MMP9  +++ ++ +++ 
Number of +’s represents relative strength of substrate cleavage; , no
activity observed.
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ting limb with especially high levels of transcript in the basal
cell layer of the WE/AEC, bone marrow cells, and the
internal limb cells in the region of muscle dedifferentiation.
MMP3/10a is expressed only in the WE at day 1, while
MMP9 is expressed in bone marrow cells, the basal layer of
the WE/AEC, periosteal cells, and near the region of muscle
dedifferentiation. Given that both nCol and MMP9 exhibit
bimodal expression patterns, we performed in situ hybrid-
ization on limb regenerates during the second wave of
expression. At day 15 postamputation, nCol and MMP9exhibited greatly expanded spatial expression patterns (Figs.
3C, D, G, and H) with both genes being highly expressed in
the cells of the blastema, as well as the cells of the AEC,
periosteum, and bone marrow.
Purified newt MMPs are biochemically functional and
exhibit substrate specificity
Recombinant newt MMPs containing a FLAG-tag on
their C-terminal ends were purified by affinity chromatog-
raphy (Fig. 4). Upon activation with APMA, each of the
purified MMP proteins exhibited its own substrate profile
when tested using gelatin and casein zymography, a rat tail
type I collagen digestion assay, and DQ- and BODIPY-
substrate analyses (Figs. 5A–C; Table 1). DQ- and
BODIPY-substrates consist of proteins that have been
labeled with fluorescent dyes to such a high degree that
the fluorescence is quenched by intramolecular interactions
between the dye molecules. When the protein is digested
by MMPs, the intramolecular quenching ceases and there
is a dramatic increase in fluorescence that is proportional to
MMP activity. By using the above assays, we showed that
nCol readily digested native rat tail type I collagen to
produce the typical TCA (3/4) and TCB (1/4) collagen
fragments but failed to digest gelatin, casein, collagen IV,
or a processed form of collagen I. These results confirm
that nCol is a true collagenase, but unlike Xenopus
MMP18, its closest relative, it does not digest gelatin
(Stolow et al., 1996). MMP3/10b readily digested gelatin,
casein, collagen IV, and processed collagen I, and exhibited
an atypical activity toward native rat tail type I collagen by
generating several small collagen degradation products
with sizes b25 kDa (Fig. 5B). Therefore, MMP3/10b acts
both as a stromelysin and noncanonical collagenase.
MMP3/10a digested gelatin, casein, collagen IV, and
processed collagen I; however, it exhibited little, if any,
activity toward native rat tail type I collagen. Newt MMP9
digested gelatin, collagen IV, processed collagen I, but not
casein and native rat tail type I collagen.
Treatment of regenerating newt limbs with GM6001 leads to
aberrant limb regenerates
All purified newt MMPs and MMPs identified in the
newt extracts were completely inhibited by 50 AM
V. Vinarsky et al. / Developmental Biology 279 (2005) 86–9894GM6001, except for some residual activity of the 20 kDa
MMP (Fig. 6). However, this residual activity, presumably
due to a processed form of MMP3/10b (see above), was
less than the activity observed in unamputated newt limbs.
To determine whether MMPs might be required for normal
limb regeneration, we amputated newt forelimbs through
the stylopodium midway between the shoulder and elbow
and within an hour of amputation placed the newts in
dechlorinated tap water containing 50 AM GM6001 and
1% DMSO. The DMSO was present for two reasons: (1)
it is a preferred solvent for GM6001 and (2) it is thoughtFig. 6. GM6001 inhibits newt MMP proteolytic activity. (A) GM6001 inhibits n
nCol-mediated cleavage of native rat tail type I collagen (Rat Col I) to form the
concentrations of 2 AM, GM6001 inhibits MMP3/10b against all tested substrate
each substrate. Gray triangles represent the activity of MMP3/10b against each s
10a, MMP9, and all MMPs found in the regenerating newt limb that cleave gela
MMP, presumably a processed form of MMP3/10b, remains even at 50 AM GM
limbs.to allow passage of GM6001 through the extracellular
spaces between epithelial cells (Zhang and Sarras, 1994).
Newts were housed continually in the GM6001/DMSO
solution for 60 days while their limbs regenerated. Control
newts were placed in 1% DMSO or dechlorinated tap
water for the entire regenerative period. Following
regeneration, the limbs were examined for general
morphological and histological abnormalities. All 10
GM6001-treated limbs exhibited abnormalities, while the
6 DMSO-treated limbs and all water control limbs
exhibited normal regenerative morphology. Using theCol activity. At concentrations z2 AM, GM6001 completely inhibits the
TCA and TCB fragments. 1% DMSO does not inhibit nCol activity. (B) At
s. Black asterisks represent the activity of uninhibited MMP3/10b against
ubstrate in the presence of 2 AM GM6001. (C) GM6001 inhibits MMP3/
tin and/or casein during gel zymography. Residual activity of the 20 kDa
6001; however, this activity is below that observed in unamputated newt
V. Vinarsky et al. / Developmental Biology 279 (2005) 86–98 95Fischer–Irwin exact test, the difference in outcome
between GM6001- and DMSO-treated limbs is statistically
significant at P = 0.0001.
Most of the GM6001-treated limbs (8 out of 10) were
dwarfed and appeared inflexible at the elbow. Hematox-
ylin- and eosin-stained sections of these limbs also
revealed abnormalities (Fig. 7). The dwarfed limbs had
shorter regenerated humeri, ulnae, and radii than their
control counterparts (Figs. 7B and C; Table 2). Inaddition, each of the regenerated humeri in GM6001-
treated limbs lacked a well-formed, rounded distal
epiphysis, which resulted in an aberrant articulation with
the radius and ulna. This aberrant joint most likely
explains the observation that the GM6001-treated limbs
appeared to be inflexible at the elbow. Limbs from control
newts did not exhibit these abnormalities. The regenerated
portion of the humeri in GM6001-treated limbs was, on
average, 48% the length of regenerated control humeri,
while the regenerated ulnae and radii of treated newts
were 52% and 53% the length of their corresponding
DMSO controls, respectively (Table 2). These differences
in mean length are statistically significant. No statistically
significant differences in the widths of the regenerated
bones are observed. In 2 out of 10 limbs, regeneration was
halted at an early stage and only a healed stump was
observed (Fig. 7D). Histological analysis revealed that the
distal end of these stumps was covered by an uncharac-
terized acellular scar-like substance.Discussion
Our results strongly suggest that MMPs are required for
normal newt limb regeneration. First, all newts treated with
the MMP inhibitor GM6001 either failed to regenerate
their limbs or regenerated abnormal limbs, while newts
treated with the vehicle alone exhibited no impairment in
regeneration. GM6001 is a potent inhibitor of metal-
loproteases that has been used extensively to inhibit
MMP proteolytic activity both in vitro and in vivo
(Alexander et al., 1996; Gijbels et al., 1994; Grobelny et
al., 1992; Kheradmand et al., 2002; Leontovich et al.,
2000; Solberg et al., 2003; Wiseman et al., 2003). Second,
MMP expression and activity are highly elevated within
hours of limb amputation, suggesting that these proteases
play an important role in the initial stages of limb
regeneration. Third, the expression of MMP3/10b, nCol,
and MMP9 in tissues undergoing histolysis (Fig. 3)
suggests that these MMPs contribute to the histolytic
process during regeneration.Fig. 7. Inhibition of MMP proteolytic activity by GM6001 during newt
limb regeneration produces dwarfed and malformed limbs. (A) Section of
the stylopodium and zeugopodium of a regenerated control limb treated
with 1% DMSO throughout the 60-day regenerative period. Note that
ossification of the regenerated radius is beginning in the diaphysis as
described previously (Stock et al., 2003) (green arrowhead). (B) Section of
the stylopodium and zeugopodium of a regenerated limb treated with 50 AM
GM6001 throughout the 60-day regenerative period. (C) Section of the
zeugopodium and autopodium of a regenerated limb treated with 50 AM
GM6001 throughout the 60-day regenerative period. (D) Section of a limb
treated with 50 AM GM6001 for 60 days that failed to regenerate. Note the
acellular scar-like substance at the distal end of the limb stump (white
arrow). Black arrows denote approximate amputation plane. h, regenerated
humerus; r, regenerated radius; u, regenerated ulna; c, regenerated carpal
bone.
Table 2
Inhibitory effects of GM6001 on newt limb regeneration
Treatment Regenerated humerusa Regenerated ulnaa Regenerated radiusa
Length (Am) Width (Am) Length (Am) Width (Am) Length (Am) Width (Am)
DMSO 1408 F 82 578 F 122 1702 F 339 308 F 73 1646 F 308 375 F 50
GM6001 671 F 156 665 F 85 881 F 359 384 F 107 869 F 331 406 F 132
P value 4.1  108b 8.1  102 8.1  104b 7.7  102 6.2  104b 2.8  101
a Measurements are given as the mean F the standard deviation.
b Statistically significant results between the DMSO control and GM6001-treated limbs.
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were hypomorphic and malformed. This phenotype is
consistent with other studies that have addressed the role
of MMPs during mouse development or regeneration in
less complex organisms. In our study, the regenerated
humeri, radii, and ulnae of newts treated with GM6001
were about 50% the length of the corresponding control
bones. In comparison, mice that are deficient for MMP14
develop dwarfed limbs that are about 65% the length of
their wild type littermates (Holmbeck et al., 1999). Hydra
foot regeneration (Leontovich et al., 2000) and intestinal
regeneration in the sea cucumber Holothuria glaberrima
(Quinones et al., 2002) are impaired by MMP inhibition.
These similarities in response to MMP deficiency or
inhibition suggest that MMPs play important roles in the
development and regeneration of complex structures.
Expression studies of MMPs during salamander spinal
cord regeneration (Chernoff et al., 2000) and ear hole
regeneration in MRL mice (Gourevitch et al., 2003) are
consistent with this interpretation.
It is reasonable to propose that MMPs might be
involved in the formation, maintenance, and growth of
the regeneration blastema, given that they are initially
expressed in tissues that contribute to blastema formation
and then later in the blastema itself (see Fig. 3). For
example, the bimodal expression patterns of nCol and
MMP9 suggest that these two MMPs each have dual roles
during regeneration, one very early in the process when
cells are receiving the initial dedifferentiation signals and
the other several days later during the stage of blastemal
growth. MMP9 exhibits a similar bimodal expression
pattern during limb regeneration in the axolotl Ambystoma
mexicanum (Yang et al., 1999), providing further evidence
for a potential dual role for this MMP. Our in situ
hybridization data are consistent with such an interpreta-
tion. During the first few days of regeneration, nCol and
MMP9 are expressed in periosteal and/or muscle cells,
which dedifferentiate and contribute to the formation of
the blastema (Hay and Fischman, 1961). During the
second wave of expression, both nCol and MMP9 have
greatly expanded their expression domains to include
blastemal cells, suggesting that these genes are also
important for blastemal growth or maintenance. The
expression of MMP3/10b in tissues that are about to
undergo dedifferentiation further strengthens our hypoth-
esis. It has been shown that MMP3, a mammalianstromelysin related to newt MMP3/10b, can promote the
spontaneous development of hyperplasia, dysplasia, and
carcinoma in mammary glands of transgenic mice (Stern-
licht et al., 1999, 2000). This suggests that stromelysins,
such as MMP3/10b, could act to promote cell trans-
formation and proliferation, which are events similar to
those occurring during the dedifferentiation and blastemal
stages of limb regeneration. MMP3/10b has the highest
upregulation of the MMP genes and likely encodes the
prominent 20 kDa MMP present in early limb regenerates.
MMP3/10b also exhibits an unusual set of proteolytic
activities (see Fig. 5), which could be the reason for its
apparent importance during limb regeneration. The two
phenotypes we observed in our MMP inhibitor studies are
also consistent with the hypothesis that MMPs are involved
in blastema formation, maintenance, and growth. Reduced
blastema size due to insufficient cellular dedifferentiation or
proliferation could explain both the presence of limb stumps
and the development of dwarfed limbs following MMP
inhibition.
MMPs could exert their effects on regeneration by
preventing scar formation while promoting the production
of an ECM that is conducive to blastema formation and
growth. This interpretation is consistent with our data. Two
of the GM6001-treated limbs completely failed to regen-
erate and instead formed an acellular scar-like structure on
the distal end of the limb stump. This possible mechanism
of MMP function was first proposed by Grillo et al.
(1968), and since that time, ample evidence has been
generated that suggests there is an antithetical relationship
between scar formation and regeneration. Midgestational
fetal mammalian skin can regenerate perfectly following an
incisional wound, while postnatal and adult skin respond to
similar wounds by forming a scar (Bullard et al., 1997;
Colwell et al., 2003; Lovvorn et al., 1999). When fetal skin
is injected with TGFh1, MMP1 levels are reduced and
scars are formed (Bullard et al., 1997), suggesting that high
MMP levels may prevent scar formation during fetal skin
regeneration. Furthermore, zebrafish normally regenerate
their heart ventricles following the apical excision of 20–
30% of the ventricle (Poss et al., 2002; Raya et al., 2003);
however, a mutation in an essential regeneration gene leads
to scar formation instead of regeneration (Poss et al.,
2002). Given the antithetical relationship between regen-
eration and scar formation and the known biochemical
functions of MMPs, it is not surprising that MMPs might
V. Vinarsky et al. / Developmental Biology 279 (2005) 86–98 97function to prevent scar formation while promoting an
ECM conducive to regeneration.
MMPs could exert their biological functions during
regeneration through a variety of mechanisms. As men-
tioned above, they could influence blastemal formation by
selectively degrading components of the ECM. Alterna-
tively, they are known to be involved in several biological
activities including the activation of latent MMPs (Stern-
licht and Werb, 2001; Strongin et al., 1995), cytokines
(Schonbeck et al., 1998; Yu and Stamenkovic, 2000), and
small biopeptides (Dong et al., 1997; Patterson and Sang,
1997), the release of trapped growth factors bound to either
the ECM or non-matrix proteins (Fowlkes et al., 1994a,b,
1995; Imai et al., 1997; Thrailkill et al., 1995; Whitelock
et al., 1996), the cleavage of cell surface proteins (Haro et
al., 2000; Kayagaki et al., 1995; Levi et al., 1996; Noe et al.,
2001; Sheu et al., 2001), and the initiation of intracellular
signaling pathways (Conant et al., 2002; Galt et al., 2002).
Any or all of these biological functions could be required for
the formation, growth, and maintenance of the regeneration
blastema.
In summary, MMPs appear to be required for normal
regeneration in a variety of organisms including newts,
hydra, and sea cucumbers. This convergence on a set of
required regeneration genes in three species, each represent-
ing a different phylum, suggests that there may be a
common set of molecular factors and pathways that govern
most regenerative processes. If so, it will be important to
study regeneration in a wide variety of organisms, so that
these common molecular pathways can be identified. Such
knowledge will lead to a better understanding of the
molecular basis for regeneration and may foster rational
therapies for regenerative medicine.Acknowledgments
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